Covid-19 Impact on Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome), including the following market information:
Major competitors identified in this market include Aeolus Pharmaceuticals, Inc., Atox Bio Ltd, BCN Biosciences LLC, Cellphire Inc, Daiichi Sankyo Co Ltd, FirstString Research Inc, RxBio Inc, Shuttle Pharmaceuticals LLC, etc.
Based on the Region:
- Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Major competitors identified in this market include Aeolus Pharmaceuticals, Inc., Atox Bio Ltd, BCN Biosciences LLC, Cellphire Inc, Daiichi Sankyo Co Ltd, FirstString Research Inc, RxBio Inc, Shuttle Pharmaceuticals LLC, etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Blood Transfusion
- Antibiotic
- Others
- Hospital
- Clinic
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Industry
1.7 COVID-19 Impact: Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Trends
2 GLOBAL RADIATION TOXICITY (RADIATION SICKNESS, ACUTE RADIATION SYNDROME) QUARTERLY MARKET SIZE ANALYSIS
2.1 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business Impact Assessment - COVID-19
2.1.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Quarterly Market Size, 2019 VS 2020
3.2 By Players, Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Headquarters and Area Served
3.3 Date of Key Players Enter into Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market
3.4 Key Players Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON RADIATION TOXICITY (RADIATION SICKNESS, ACUTE RADIATION SYNDROME) SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Blood Transfusion
1.4.2 Antibiotic
1.4.3 Others
4.2 By Type, Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021
5 IMPACT OF COVID-19 ON RADIATION TOXICITY (RADIATION SICKNESS, ACUTE RADIATION SYNDROME) SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Hospital
5.5.2 Clinic
5.2 By Application, Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021
5.2.1 By Application, Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Aeolus Pharmaceuticals, Inc.
7.1.1 Aeolus Pharmaceuticals, Inc. Business Overview
7.1.2 Aeolus Pharmaceuticals, Inc. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Quarterly Revenue, 2020
7.1.3 Aeolus Pharmaceuticals, Inc. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product Introduction
7.1.4 Aeolus Pharmaceuticals, Inc. Response to COVID-19 and Related Developments
7.2 Atox Bio Ltd
7.2.1 Atox Bio Ltd Business Overview
7.2.2 Atox Bio Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Quarterly Revenue, 2020
7.2.3 Atox Bio Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product Introduction
7.2.4 Atox Bio Ltd Response to COVID-19 and Related Developments
7.3 BCN Biosciences LLC
7.3.1 BCN Biosciences LLC Business Overview
7.3.2 BCN Biosciences LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Quarterly Revenue, 2020
7.3.3 BCN Biosciences LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product Introduction
7.3.4 BCN Biosciences LLC Response to COVID-19 and Related Developments
7.4 Cellphire Inc
7.4.1 Cellphire Inc Business Overview
7.4.2 Cellphire Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Quarterly Revenue, 2020
7.4.3 Cellphire Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product Introduction
7.4.4 Cellphire Inc Response to COVID-19 and Related Developments
7.5 Daiichi Sankyo Co Ltd
7.5.1 Daiichi Sankyo Co Ltd Business Overview
7.5.2 Daiichi Sankyo Co Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Quarterly Revenue, 2020
7.5.3 Daiichi Sankyo Co Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product Introduction
7.5.4 Daiichi Sankyo Co Ltd Response to COVID-19 and Related Developments
7.6 FirstString Research Inc
7.6.1 FirstString Research Inc Business Overview
7.6.2 FirstString Research Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Quarterly Revenue, 2020
7.6.3 FirstString Research Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product Introduction
7.6.4 FirstString Research Inc Response to COVID-19 and Related Developments
7.7 RxBio Inc
7.7.1 RxBio Inc Business Overview
7.7.2 RxBio Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Quarterly Revenue, 2020
7.7.3 RxBio Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product Introduction
7.7.4 RxBio Inc Response to COVID-19 and Related Developments
7.8 Shuttle Pharmaceuticals LLC
7.8.1 Shuttle Pharmaceuticals LLC Business Overview
7.8.2 Shuttle Pharmaceuticals LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Quarterly Revenue, 2020
7.8.3 Shuttle Pharmaceuticals LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product Introduction
7.8.4 Shuttle Pharmaceuticals LLC Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Industry
1.7 COVID-19 Impact: Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Trends
2 GLOBAL RADIATION TOXICITY (RADIATION SICKNESS, ACUTE RADIATION SYNDROME) QUARTERLY MARKET SIZE ANALYSIS
2.1 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business Impact Assessment - COVID-19
2.1.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Quarterly Market Size, 2019 VS 2020
3.2 By Players, Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Headquarters and Area Served
3.3 Date of Key Players Enter into Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market
3.4 Key Players Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON RADIATION TOXICITY (RADIATION SICKNESS, ACUTE RADIATION SYNDROME) SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Blood Transfusion
1.4.2 Antibiotic
1.4.3 Others
4.2 By Type, Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021
5 IMPACT OF COVID-19 ON RADIATION TOXICITY (RADIATION SICKNESS, ACUTE RADIATION SYNDROME) SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Hospital
5.5.2 Clinic
5.2 By Application, Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021
5.2.1 By Application, Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Aeolus Pharmaceuticals, Inc.
7.1.1 Aeolus Pharmaceuticals, Inc. Business Overview
7.1.2 Aeolus Pharmaceuticals, Inc. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Quarterly Revenue, 2020
7.1.3 Aeolus Pharmaceuticals, Inc. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product Introduction
7.1.4 Aeolus Pharmaceuticals, Inc. Response to COVID-19 and Related Developments
7.2 Atox Bio Ltd
7.2.1 Atox Bio Ltd Business Overview
7.2.2 Atox Bio Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Quarterly Revenue, 2020
7.2.3 Atox Bio Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product Introduction
7.2.4 Atox Bio Ltd Response to COVID-19 and Related Developments
7.3 BCN Biosciences LLC
7.3.1 BCN Biosciences LLC Business Overview
7.3.2 BCN Biosciences LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Quarterly Revenue, 2020
7.3.3 BCN Biosciences LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product Introduction
7.3.4 BCN Biosciences LLC Response to COVID-19 and Related Developments
7.4 Cellphire Inc
7.4.1 Cellphire Inc Business Overview
7.4.2 Cellphire Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Quarterly Revenue, 2020
7.4.3 Cellphire Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product Introduction
7.4.4 Cellphire Inc Response to COVID-19 and Related Developments
7.5 Daiichi Sankyo Co Ltd
7.5.1 Daiichi Sankyo Co Ltd Business Overview
7.5.2 Daiichi Sankyo Co Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Quarterly Revenue, 2020
7.5.3 Daiichi Sankyo Co Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product Introduction
7.5.4 Daiichi Sankyo Co Ltd Response to COVID-19 and Related Developments
7.6 FirstString Research Inc
7.6.1 FirstString Research Inc Business Overview
7.6.2 FirstString Research Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Quarterly Revenue, 2020
7.6.3 FirstString Research Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product Introduction
7.6.4 FirstString Research Inc Response to COVID-19 and Related Developments
7.7 RxBio Inc
7.7.1 RxBio Inc Business Overview
7.7.2 RxBio Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Quarterly Revenue, 2020
7.7.3 RxBio Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product Introduction
7.7.4 RxBio Inc Response to COVID-19 and Related Developments
7.8 Shuttle Pharmaceuticals LLC
7.8.1 Shuttle Pharmaceuticals LLC Business Overview
7.8.2 Shuttle Pharmaceuticals LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Quarterly Revenue, 2020
7.8.3 Shuttle Pharmaceuticals LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product Introduction
7.8.4 Shuttle Pharmaceuticals LLC Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Assessment
Table 9. COVID-19 Impact: Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Trends
Table 10. COVID-19 Impact Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size
Table 11. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Growth Drivers
Table 14. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Restraints
Table 15. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Opportunities
Table 16. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Challenges
Table 17. By Players, Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market
Table 21. Key Players Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size 2019-2021, (US$ Million)
Table 24. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 57. Aeolus Pharmaceuticals, Inc. Business Overview
Table 58. Aeolus Pharmaceuticals, Inc. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Aeolus Pharmaceuticals, Inc. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
Table 60. Aeolus Pharmaceuticals, Inc. Response to COVID-19 and Related Developments
Table 61. Atox Bio Ltd Business Overview
Table 62. Atox Bio Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Atox Bio Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
Table 64. Atox Bio Ltd Response to COVID-19 and Related Developments
Table 65. BCN Biosciences LLC Business Overview
Table 66. BCN Biosciences LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. BCN Biosciences LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
Table 68. BCN Biosciences LLC Response to COVID-19 and Related Developments
Table 69. Cellphire Inc Business Overview
Table 70. Cellphire Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Cellphire Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
Table 72. Cellphire Inc Response to COVID-19 and Related Developments
Table 73. Daiichi Sankyo Co Ltd Business Overview
Table 74. Daiichi Sankyo Co Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Daiichi Sankyo Co Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
Table 76. Daiichi Sankyo Co Ltd Response to COVID-19 and Related Developments
Table 77. FirstString Research Inc Business Overview
Table 78. FirstString Research Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. FirstString Research Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
Table 80. FirstString Research Inc Response to COVID-19 and Related Developments
Table 81. RxBio Inc Business Overview
Table 82. RxBio Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. RxBio Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
Table 84. RxBio Inc Response to COVID-19 and Related Developments
Table 85. Shuttle Pharmaceuticals LLC Business Overview
Table 86. Shuttle Pharmaceuticals LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Shuttle Pharmaceuticals LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
Table 88. Shuttle Pharmaceuticals LLC Response to COVID-19 and Related Developments
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Assessment
Table 9. COVID-19 Impact: Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Trends
Table 10. COVID-19 Impact Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size
Table 11. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Growth Drivers
Table 14. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Restraints
Table 15. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Opportunities
Table 16. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Challenges
Table 17. By Players, Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market
Table 21. Key Players Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size 2019-2021, (US$ Million)
Table 24. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, 2019-2021 (US$ Million)
Table 57. Aeolus Pharmaceuticals, Inc. Business Overview
Table 58. Aeolus Pharmaceuticals, Inc. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Aeolus Pharmaceuticals, Inc. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
Table 60. Aeolus Pharmaceuticals, Inc. Response to COVID-19 and Related Developments
Table 61. Atox Bio Ltd Business Overview
Table 62. Atox Bio Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Atox Bio Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
Table 64. Atox Bio Ltd Response to COVID-19 and Related Developments
Table 65. BCN Biosciences LLC Business Overview
Table 66. BCN Biosciences LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. BCN Biosciences LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
Table 68. BCN Biosciences LLC Response to COVID-19 and Related Developments
Table 69. Cellphire Inc Business Overview
Table 70. Cellphire Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Cellphire Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
Table 72. Cellphire Inc Response to COVID-19 and Related Developments
Table 73. Daiichi Sankyo Co Ltd Business Overview
Table 74. Daiichi Sankyo Co Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Daiichi Sankyo Co Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
Table 76. Daiichi Sankyo Co Ltd Response to COVID-19 and Related Developments
Table 77. FirstString Research Inc Business Overview
Table 78. FirstString Research Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. FirstString Research Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
Table 80. FirstString Research Inc Response to COVID-19 and Related Developments
Table 81. RxBio Inc Business Overview
Table 82. RxBio Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. RxBio Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
Table 84. RxBio Inc Response to COVID-19 and Related Developments
Table 85. Shuttle Pharmaceuticals LLC Business Overview
Table 86. Shuttle Pharmaceuticals LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Shuttle Pharmaceuticals LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
Table 88. Shuttle Pharmaceuticals LLC Response to COVID-19 and Related Developments
LIST OF FIGURES
Figure 1. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product Picture
Figure 2. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Market Share, 2019-2021
Figure 1. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product Picture
Figure 2. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Market Share, 2019-2021
